Please be advised that the format of evaluation reports shared on the NICE website has recently changed, for ease of user navigation between individual documents contained in the report.

It is a requirement of the new (PDF portfolio) format that Adobe Reader is used to view the document. Please follow the link at the bottom of this page to download Adobe Reader if required.

If you have any feedback on the new format please contact the Project Manager for this appraisal.

Multiple myeloma - bortezomib (induction therapy): evaluation report

01.  NICE’s response to comments on the Appraisal Consultation Document (ACD)

02.  Consultee comments on the ACD – Janssen

03.  Consultee comments on the ACD – Myeloma UK

04.  Consultee comments on the ACD – UK Myeloma Forum

05.  ERG critique of minded no response

06.  Evidence Review Group additional analysis

If you cannot open this document, you may have to save to your device and open.